• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌患者焦虑轨迹预测模型的开发与验证:一项回顾性研究

Development and Validation of a Predictive Model for Anxiety Trajectories in Patients with Breast Cancer: A Retrospective Study.

作者信息

Li Xia, Wei Ben-Kai, Li Fan, Yan Huan-Huan, Shen Jun

机构信息

Department of Breast Surgery, the First People's Hospital of Lianyungang, The Affiliated Hospital of Xuzhou Medical University, Lianyungang, 222000, Jiangsu Province, People's Republic of China.

Department of General Surgery, the First People's Hospital of Lianyungang, The Affiliated Hospital of Xuzhou Medical University, Lianyungang, 222000, Jiangsu Province, People's Republic of China.

出版信息

Psychol Res Behav Manag. 2025 Feb 15;18:315-329. doi: 10.2147/PRBM.S501127. eCollection 2025.

DOI:10.2147/PRBM.S501127
PMID:39980876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11840338/
Abstract

OBJECTIVE

This study aims to develop and validate a predictive model for short-term post-treatment anxiety trajectories in patients with breast cancer, utilizing baseline patient characteristics and initial anxiety scores to inform precise clinical interventions.

METHODS

Baseline characteristics were collected from 424 patients diagnosed with breast cancer who underwent surgical treatment at our hospital between January 1, 2021, and December 30, 2022. Anxiety levels were assessed using the Self-Rating Anxiety Scale (SAS) scores at admission and at 3-, 6-, 9-, and 12-months post-treatment. Distinct trajectories of SAS score changes were identified and categorized. Variables were screened, and multiple models were developed. The optimal model was identified through comparative analysis, and a nomogram was generated following model simplification.

RESULTS

We found three distinct trends in the trajectory of anxiety, but we grouped them into two broad categories: gradual reduction of anxiety and persistent anxiety. LM Model was established by logistic regression, and Model 1 and Model 2 were established by Random Forest (RF) and eXtreme Gradient Boosting (Xgboost) screening variables. The ROC curve areas in the validation set were 0.822 (0.757-0.887), 0.757 (0.680-0.834) and 0.781 (0.710-0.851), respectively. Model comparison, using Net Reclassification Improvement (NRI) and Integrated Discrimination Improvement (IDI), identified the Lm model as optimal, which underwent further simplification and value assignment. Decision Curve Analysis (DCA) and Clinical Impact Curve (CIC) analyses confirmed the superiority of model-based interventions over general interventions.

CONCLUSION

Distinct anxiety trajectories are observed in patients diagnosed with breast cancer during the first 12 months post-treatment. Predictive modeling based on baseline characteristics is feasible although though further research is warranted.

摘要

目的

本研究旨在开发并验证一种针对乳腺癌患者治疗后短期焦虑轨迹的预测模型,利用患者的基线特征和初始焦虑评分来指导精准的临床干预。

方法

收集了2021年1月1日至2022年12月30日期间在我院接受手术治疗的424例乳腺癌患者的基线特征。采用自评焦虑量表(SAS)在入院时以及治疗后3、6、9和12个月评估焦虑水平。识别并分类SAS评分变化的不同轨迹。筛选变量并开发多个模型。通过比较分析确定最佳模型,并在模型简化后生成列线图。

结果

我们在焦虑轨迹中发现了三种不同趋势,但将它们分为两大类:焦虑逐渐减轻和持续性焦虑。通过逻辑回归建立了LM模型,通过随机森林(RF)和极端梯度提升(Xgboost)筛选变量建立了模型1和模型2。验证集中的ROC曲线面积分别为0.822(0.757 - 0.887)、0.757(0.680 - 0.834)和0.781(0.710 - 0.851)。使用净重新分类改善(NRI)和综合辨别改善(IDI)进行模型比较,确定LM模型为最佳模型,该模型进一步简化并赋值。决策曲线分析(DCA)和临床影响曲线(CIC)分析证实了基于模型的干预优于一般干预。

结论

在确诊为乳腺癌的患者治疗后的前12个月观察到不同的焦虑轨迹。基于基线特征的预测建模是可行的,尽管仍需进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eff/11840338/96d6f4b63d2f/PRBM-18-315-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eff/11840338/09fae32c3d6d/PRBM-18-315-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eff/11840338/a44e42160ce0/PRBM-18-315-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eff/11840338/e6737d61adc3/PRBM-18-315-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eff/11840338/7f99d04618f9/PRBM-18-315-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eff/11840338/96d6f4b63d2f/PRBM-18-315-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eff/11840338/09fae32c3d6d/PRBM-18-315-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eff/11840338/a44e42160ce0/PRBM-18-315-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eff/11840338/e6737d61adc3/PRBM-18-315-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eff/11840338/7f99d04618f9/PRBM-18-315-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eff/11840338/96d6f4b63d2f/PRBM-18-315-g0005.jpg

相似文献

1
Development and Validation of a Predictive Model for Anxiety Trajectories in Patients with Breast Cancer: A Retrospective Study.乳腺癌患者焦虑轨迹预测模型的开发与验证:一项回顾性研究
Psychol Res Behav Manag. 2025 Feb 15;18:315-329. doi: 10.2147/PRBM.S501127. eCollection 2025.
2
Establishment and Validation of a Predictive Model for Post-Treatment Anxiety Based on Patient Attributes and Pre-Treatment Anxiety Scores.基于患者属性和治疗前焦虑评分的治疗后焦虑预测模型的建立与验证
Psychol Res Behav Manag. 2023 Sep 19;16:3883-3894. doi: 10.2147/PRBM.S425055. eCollection 2023.
3
Development and validation of a neoadjuvant chemotherapy pathological complete remission model based on Reg IV expression in breast cancer tissues: a clinical retrospective study.基于 Reg IV 表达的乳腺癌组织新辅助化疗病理完全缓解模型的建立和验证:一项临床回顾性研究。
Breast Cancer. 2024 Sep;31(5):955-968. doi: 10.1007/s12282-024-01609-y. Epub 2024 Jul 8.
4
Development and Validation of a Clinical Model for Predicting Delay in Postoperative Transfer Out of the Post-Anesthesia Care Unit: A Retrospective Cohort Study.预测术后转出麻醉后护理单元延迟的临床模型的开发与验证:一项回顾性队列研究
J Multidiscip Healthc. 2024 May 22;17:2535-2550. doi: 10.2147/JMDH.S458784. eCollection 2024.
5
Development and Validation of a Diagnostic Model for Enhancing Lesions on Breast MRI: Based on Kaiser Score.基于凯泽评分的乳腺MRI强化病变诊断模型的开发与验证
Acad Radiol. 2025 Feb;32(2):664-680. doi: 10.1016/j.acra.2024.09.028. Epub 2024 Sep 24.
6
Development and validation of a dynamic contrast-enhanced magnetic resonance imaging-based habitat and peritumoral radiomic model to predict axillary lymph node metastasis in patients with breast cancer: a retrospective study.基于动态对比增强磁共振成像的乳腺癌患者腋窝淋巴结转移预测的瘤周放射组学模型的开发与验证:一项回顾性研究
Quant Imaging Med Surg. 2024 Dec 5;14(12):8211-8226. doi: 10.21037/qims-24-558. Epub 2024 Oct 31.
7
[Constructing a predictive model for the death risk of patients with septic shock based on supervised machine learning algorithms].基于监督机器学习算法构建脓毒症休克患者死亡风险预测模型
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 Apr;36(4):345-352. doi: 10.3760/cma.j.cn121430-20230930-00832.
8
Risk factor analysis and nomogram model of DVT in hip fracture patients at hospital admission.髋部骨折患者入院时深静脉血栓形成的危险因素分析及列线图模型
BMC Musculoskelet Disord. 2025 Feb 25;26(1):189. doi: 10.1186/s12891-025-08308-5.
9
Risk factors of lymph node metastasis or lymphovascular invasion for superficial esophageal squamous cell carcinoma: A practical and effective predictive nomogram based on a cancer hospital data.食管浅表鳞状细胞癌淋巴结转移或淋巴管侵犯的危险因素:基于某癌症医院数据的实用且有效的预测列线图
Front Med (Lausanne). 2022 Nov 17;9:1038097. doi: 10.3389/fmed.2022.1038097. eCollection 2022.
10
Machine learning for epithelial ovarian cancer platinum resistance recurrence identification using routine clinical data.利用常规临床数据通过机器学习识别上皮性卵巢癌铂耐药复发情况。
Front Oncol. 2024 Nov 8;14:1457294. doi: 10.3389/fonc.2024.1457294. eCollection 2024.

本文引用的文献

1
Long-term behavioral symptom clusters among survivors of early-stage breast cancer: Development and validation of a predictive model.早期乳腺癌幸存者的长期行为症状群:一种预测模型的开发与验证
J Natl Cancer Inst. 2025 Jan 1;117(1):89-102. doi: 10.1093/jnci/djae222.
2
Disparities in 36 cancers across 185 countries: secondary analysis of global cancer statistics.185 个国家 36 种癌症的差异:全球癌症统计数据的二次分析。
Front Med. 2024 Oct;18(5):911-920. doi: 10.1007/s11684-024-1058-6. Epub 2024 Aug 21.
3
Global cancer statistics 2022: The report offers a view on disparities in the incidence and mortality of cancer by sex and region worldwide and on the areas needing attention.
《2022年全球癌症统计数据》:该报告呈现了全球范围内癌症发病率和死亡率在性别及地区方面的差异情况,以及需要关注的领域。
Cancer. 2024 Aug 1;130(15):2568. doi: 10.1002/cncr.35444.
4
Personalized and continuous care intervention affects rehabilitation, living quality, and negative emotions of patients with breast cancer.个性化持续护理干预对乳腺癌患者的康复、生活质量及负性情绪有影响。
World J Psychiatry. 2024 Jun 19;14(6):876-883. doi: 10.5498/wjp.v14.i6.876.
5
Development and validation of a nomogram model of depression and sleep disorders and the risk of disease progression in patients with breast cancer.开发和验证用于乳腺癌患者抑郁和睡眠障碍以及疾病进展风险的列线图模型。
BMC Womens Health. 2024 Jul 3;24(1):385. doi: 10.1186/s12905-024-03222-9.
6
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
7
Establishment and Validation of a Predictive Model for Post-Treatment Anxiety Based on Patient Attributes and Pre-Treatment Anxiety Scores.基于患者属性和治疗前焦虑评分的治疗后焦虑预测模型的建立与验证
Psychol Res Behav Manag. 2023 Sep 19;16:3883-3894. doi: 10.2147/PRBM.S425055. eCollection 2023.
8
Patient-reported outcomes and hospitalization data in patients with HER2-positive metastatic breast cancer receiving trastuzumab deruxtecan or trastuzumab emtansine in the phase III DESTINY-Breast03 study.在 III 期 DESTINY-Breast03 研究中,接受曲妥珠单抗 deruxtecan 或曲妥珠单抗 emtansine 的 HER2 阳性转移性乳腺癌患者的患者报告结局和住院数据。
Ann Oncol. 2023 Jul;34(7):569-577. doi: 10.1016/j.annonc.2023.04.516. Epub 2023 May 12.
9
Depression, anxiety and related factors among Syrian breast cancer patients: a cross-sectional study.叙利亚乳腺癌患者的抑郁、焦虑及相关因素:一项横断面研究。
BMC Psychiatry. 2022 Dec 17;22(1):796. doi: 10.1186/s12888-022-04469-y.
10
Group-based trajectory and predictors of anxiety and depression among Chinese breast cancer patients.基于群组的轨迹和中国乳腺癌患者焦虑和抑郁的预测因素。
Front Public Health. 2022 Oct 10;10:1002341. doi: 10.3389/fpubh.2022.1002341. eCollection 2022.